Job Description

The Position

Senior Global Leadership Opportunity – Medical Affairs Obesity Triple Agonist
Are you ready to shape the medical strategy for a first‑in‑class obesity triple agonist with the potential to redefine chronic weight management? We are seeking an accomplished Medical Affairs leader to establish and lead the global Medical Affairs strategy and organization for this asset, which has recently achieved proof of concept.
This is a pivotal leadership role with responsibility for driving scientific, clinical, and medical excellence across the full asset lifecycle—from late clinical development through launch and beyond. You will play a central role in translating science into value by shaping evidence generation, external engagement, and scientific communication in one of the fastest‑growing and most competitive therapeutic areas.
As a core member of the Global Brand (Asset/Product) Leadership Team, the role provides strategic input into overarching asset decisions, partnering closely with Global Development, Market Access, Commercial, and other key functions. The position and operates with enterprise‑level accountability, with high visibility and engagement with the Executive Committee on critical asset strategy, evidence, and launch‑readiness topics.
You will build, lead, and develop a high‑performing global Medical Affairs organization, ensuring external credibility, medical rigor, and impactful scientific engagement across regions and markets worldwide.

Tasks & responsibilities

• Lead the global Medical Affairs strategy for the obesity triple agonist across development, launch, and lifecycle
• Represent Medical Affairs on the Global Brand Leadership Team, contributing to governance and strategic decision‑making
• Provide medical leadership for Phase III development, indication strategy, and lifecycle planning
• Drive the Integrated Evidence Plan (IEP) in collaboration with Clinical Development, Market Access, and Evidence Generation
• Lead scientific and medical engagement with Health Authorities, HTA bodies, and key external stakeholders to support future labeling, access, and adoption
• Partner with regional and local Medical Affairs teams to ensure launch readiness and post‑launch excellence globally
• Integrate clinical and real‑world evidence into clear, compelling medical narratives for internal and external use
• Build and lead a high‑performing global Medical Affairs team, developing scalable capabilities and top talent

Requirements

• M.D. or Ph.D. with extensive Medical Affairs leadership experience, within obesity, and or GLP-1 segment with strong foundational knowledge of clinical drug development
• Senior leadership experience in global, regional, and/or key‑market Medical Affairs roles, with accountability for strategy, governance, and people leadership
• Proven ability to develop externally focused, competitive Medical Affairs strategies, including experience supporting label shaping, regulatory interactions, and pre‑launch evidence readiness
• Experience supporting late‑stage development, launch preparation, and post‑launch medical excellence, including interactions with Health Authorities in major markets (e.g., US, EU)
• Strong track record of cross‑functional leadership and influence within complex global matrix environments
• Excellent communication, presentation, and influencing skills, with credibility at senior internal and external scientific levels
• Demonstrated ability to build, lead, and develop high‑performing Medical Affairs teams

Applications from persons with severe disabilities are warmly welcomed. In cases of equal qualifications, such applicants will be given preferential consideration in the selection process. [PB3]

Ready to contact us?

If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com

Recruitment process:

Step 1: Online application - The job posting is online until "May 31, 2026.
Step 2: Virtual meeting up from mid May
Step 3: On-site interviews beginning end of May

Please submit your application documents in English.